Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAL Anglo American	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 2,359 +0.4%		Neutral
ABBV AbbVie	Upgraded by	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Risinger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$176.95 +3.0%		Hold ➝ Strong-Buy
ABBV AbbVie	Upgraded by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$176.95 +3.0%	$206.00	Market Perform ➝ Outperform
ACCO ACCO Brands	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.82 +2.6%	$7.00 ➝ $7.50	Outperform ➝ Outperform
ACHC Acadia Healthcare	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.23 -0.9%	$76.00 ➝ $43.00	Overweight ➝ Overweight
ACM AECOM	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Bubes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$116.31 +3.3%	$130.00	Buy
I was wrong. Dead wrong. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.
ACM AECOM	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$116.31 +3.3%	$119.00 ➝ $129.00	Buy ➝ Buy
ADI Analog Devices	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Quatrochi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$214.59 +0.3%	$220.00	Equal Weight
ADSK Autodesk	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$321.27 +1.9%	$320.00 ➝ $375.00	Overweight ➝ Overweight
ADSK Autodesk	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$321.27 +1.9%	$300.00 ➝ $350.00	Outperform ➝ Outperform
ADSK Autodesk	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Winslow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$321.27 +1.9%	$340.00 ➝ $350.00	Overweight ➝ Overweight
ADSK Autodesk	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$321.27 +1.9%	$325.00 ➝ $358.00	Buy ➝ Buy
AEE Ameren	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$93.81 -0.2%	$88.00 ➝ $86.00	Equal Weight ➝ Equal Weight
AEP American Electric Power	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$97.59 -0.5%	$109.00 ➝ $104.00	Overweight ➝ Overweight
AFRM Affirm	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$66.55 +1.2%	$50.00 ➝ $74.00	Buy ➝ Buy
AIOT Powerfleet	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.11 +7.1%	$8.00 ➝ $10.00	Outperform ➝ Outperform
AIOT Powerfleet	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.11 +7.1%	$10.00 ➝ $15.00	Outperform ➝ Outperform
ALGM Allegro MicroSystems	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Quatrochi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.31 +2.7%	$23.00	Overweight
AME AMETEK	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$197.38 +0.8%	$205.00 ➝ $215.00	Overweight ➝ Overweight
AMPH Amphastar Pharmaceuticals	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Hughes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$45.46 +2.0%	$55.00	Equal Weight
ANTO Antofagasta	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,664.50 -1.5%		Underweight
ARM ARM	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Quatrochi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$135.99 +2.1%	$155.00	Overweight
ASGN ASGN	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Silber Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.24 +5.6%	$96.00 ➝ $100.00	Market Perform ➝ Outperform
ASTL Algoma Steel Group	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$15.71 -1.3%	C$20.00 ➝ C$22.00
ATKR Atkore	Downgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rygiel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.69 +5.3%	$135.00 ➝ $84.00	Buy ➝ Neutral
ATKR Atkore	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$89.69 +5.3%	$130.00 ➝ $115.00	Buy ➝ Buy
ATKR Atkore	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Dray Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.69 +5.3%	$99.00 ➝ $93.00	Sector Perform ➝ Sector Perform
ATO Atmos Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$150.05 -0.1%	$145.00 ➝ $143.00	Overweight ➝ Overweight
AUB Atlantic Union Bankshares	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.63 +1.8%	$42.00 ➝ $46.00	Market Perform ➝ Market Perform
AYA Aya Gold & Silver	Target Set by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$13.41 +5.1%	C$24.00	Outperform
AZN AstraZeneca	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		£104.74 +4.1%	£140	Overweight
BAH Booz Allen Hamilton	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$149.22 -0.4%	$185.00 ➝ $155.00	Hold ➝ Hold
BBY Balfour Beatty	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 440.60 +1.5%	GBX 500 ➝ GBX 575	Buy
BBY Best Buy	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$89.54 +3.5%	$111.00 ➝ $117.00	Overweight ➝ Overweight
BE Bloom Energy	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.76 +7.6%	$20.00 ➝ $30.00	Overweight ➝ Overweight
BE Bloom Energy	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.76 +7.6%	$12.00 ➝ $22.00	Hold ➝ Hold
BERY Berry Global Group	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.71 +1.1%	$82.00 ➝ $75.00	Buy ➝ Neutral
BFAM Bright Horizons Family Solutions	Upgraded by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.08 +1.8%	$140.00 ➝ $140.00	Neutral ➝ Outperform
BFAM Bright Horizons Family Solutions	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Meuler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$113.08 +1.8%		Hold ➝ Strong-Buy
BIDU Baidu	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.33 -1.6%	$135.00 ➝ $130.00	Buy ➝ Buy
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin
BIDU Baidu	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.33 -1.6%		Overweight ➝ Equal Weight
BJ BJ's Wholesale Club	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$96.74 +4.3%	$90.00 ➝ $98.00	Equal Weight ➝ Equal Weight
BJ BJ's Wholesale Club	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$96.74 +4.3%	$95.00 ➝ $110.00	Buy ➝ Buy
BJ BJ's Wholesale Club	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$96.74 +4.3%	$102.00 ➝ $108.00	Buy ➝ Buy
BL BlackLine	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$62.70 +1.6%	$81.00 ➝ $86.00	Market Outperform ➝ Market Outperform
BME B&M European Value Retail	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 346.30 +2.2%	475.00	Buy
BME B&M European Value Retail	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 346.30 +2.2%	GBX 540 ➝ GBX 510	Buy
BME B&M European Value Retail	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 346.30 +2.2%	GBX 600 ➝ GBX 565	Buy
BREE Breedon Group	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 466.50 +3.2%	GBX 575	Outperform
BREE Breedon Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 466.50 +3.2%	GBX 520	Buy
CACI CACI International	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$468.78 -1.4%	$650.00 ➝ $550.00	Buy ➝ Buy
CARG CarGurus	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.62 -0.3%	$41.00 ➝ $46.00	Market Outperform ➝ Market Outperform
CARR Carrier Global	Initiated by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$77.00 +1.3%		Neutral
CATX Perspective Therapeutics	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.47 +15.7%	$22.00 ➝ $16.00	Outperform ➝ Outperform
CBG Close Brothers Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 200.40 -6.5%	GBX 610	Buy
CCO Cameco	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$84.01 -1.3%	C$81.00 ➝ C$88.00
CDNS Cadence Design Systems	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Mobley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$311.87 +1.7%	$350.00	Overweight
CDXS Codexis	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Kluska Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.61 +6.5%	$11.00 ➝ $11.00	Overweight ➝ Overweight
CHWY Chewy	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.89 -2.7%	$24.00 ➝ $28.00	Hold ➝ Hold
CLNN Clene	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.17 +4.0%	$90.00 ➝ $84.00	Buy ➝ Buy
CLS Celestica	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Vogt Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.16 -2.5%	$95.00	Neutral
CLS Celestica	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Vogt Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$124.54 -2.6%		Hold
CMS CMS Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$69.52 +0.4%	$69.00 ➝ $67.00	Equal Weight ➝ Equal Weight
CNP CenterPoint Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.93 +0.6%	$32.00 ➝ $31.00	Equal Weight ➝ Equal Weight
CPK Chesapeake Utilities	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$132.32 +1.5%	$118.00 ➝ $129.00	Neutral ➝ Neutral
CRM Salesforce	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$342.02 +1.9%	$342.00 ➝ $450.00	Market Outperform ➝ Market Outperform
CRM Salesforce	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$342.02 +1.9%	$275.00 ➝ $360.00	Neutral ➝ Neutral
CROX Crocs	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$106.08 +4.2%	$116.00	Buy
CRS Carpenter Technology	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$190.97 +5.7%	$220.00	Overweight
CRWD CrowdStrike	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$372.26 +4.1%	$345.00 ➝ $395.00	Overweight ➝ Overweight
CS Capstone Copper	Target Raised by	Eight Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$10.04 -2.4%	C$14.00 ➝ C$15.00
CSIQ Canadian Solar	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.91 +5.4%	$14.15	Buy
CTV Innovid	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.05 +1.3%	$3.00 ➝ $3.00	Buy ➝ Hold
CWAN Clearwater Analytics	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.94 +0.6%	$32.00 ➝ $36.00	Outperform ➝ Outperform
CYH Community Health Systems	Downgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ransom Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.65 -2.7%		Market Perform ➝ Underperform
DAVA Endava	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.67 +0.7%	$29.00	Neutral
DE Deere & Company	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$446.65 +2.1%	$496.00 ➝ $538.00	Buy ➝ Buy
DE Deere & Company	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$446.65 +2.1%	$404.00 ➝ $462.00	Neutral ➝ Neutral
DE Deere & Company	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$446.65 +2.1%	$420.00 ➝ $450.00	Neutral ➝ Neutral
DE Deere & Company	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$446.65 +2.1%	$448.00 ➝ $477.00	Outperform ➝ Outperform
DE Deere & Company	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$446.65 +2.1%	$400.00 ➝ $475.00	Overweight ➝ Overweight
DECK Deckers Outdoor	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.15 +5.6%	$218.00	Buy
DFS DFS Furniture	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 135 +1.7%		Not Rated
DML Denison Mines	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$3.32 -0.6%	C$3.50 ➝ C$3.90
DOCU DocuSign	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$83.03 +3.6%	$84.00 ➝ $108.00	Market Outperform ➝ Market Outperform
DOL Dollarama	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$145.51 -0.9%	C$147.00 ➝ C$154.00
DPLM Diploma	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 4,466 +5.8%	GBX 5,100	Buy
DPP DP Poland	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 10.50		Not Rated
DRH DiamondRock Hospitality	Downgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.16 +0.2%	$10.75 ➝ $10.25	Buy ➝ Hold
DRTS Alpha Tau Medical	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.32 +0.9%	$9.00 ➝ $9.00	Buy ➝ Buy
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW
DTE DTE Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$124.60 +0.5%	$131.00 ➝ $128.00	Overweight ➝ Overweight
DUK Duke Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$114.70 -0.1%	$122.00 ➝ $118.00	Equal Weight ➝ Equal Weight
DUOT Duos Technologies Group	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.58 -6.3%	$5.50 ➝ $10.00	Outperform ➝ Outperform
ED Consolidated Edison	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$98.36 -0.3%	$88.00 ➝ $85.00	Underweight ➝ Underweight
EIX Edison International	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.48 -0.7%	$74.00 ➝ $72.00	Underweight ➝ Underweight
EME EMCOR Group	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Bubes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$504.92 -4.2%	$445.00	Sell
EME EMCOR Group	Initiated by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$504.92 -4.2%	$600.00	Buy
EMN Eastman Chemical	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.59 +1.9%	$105.00 ➝ $105.00	Sector Perform ➝ Sector Perform
ENIC Enel Chile	Downgraded by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.70 -3.6%	$3.90 ➝ $3.90	Sector Outperform ➝ Sector Perform
ENPH Enphase Energy	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Dendrinos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$66.29 +4.3%	$85.00 ➝ $71.00	Sector Perform ➝ Sector Perform
ENPH Enphase Energy	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$66.29 +4.3%	$85.00 ➝ $70.00	Neutral ➝ Neutral
ESTC Elastic	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Ma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$108.03 +14.8%	$100.00 ➝ $120.00	Buy ➝ Buy
ESTC Elastic	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Kothari Subscribe to MarketBeat All Access for the recommendation accuracy rating	$108.03 +14.8%		Hold ➝ Strong-Buy
ESTC Elastic	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$92.00 ➝ $135.00	Sector Outperform ➝ Sector Outperform
ESTC Elastic	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$105.00 ➝ $135.00	Buy ➝ Buy
ESTC Elastic	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$110.00 ➝ $135.00	Buy ➝ Buy
ESTC Elastic	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$75.00 ➝ $115.00	Neutral ➝ Neutral
ESTC Elastic	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$110.00 ➝ $130.00	Buy ➝ Buy
ESTC Elastic	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$98.00 ➝ $132.00	Buy ➝ Buy
ESTC Elastic	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$99.00 ➝ $113.00	Neutral ➝ Neutral
ESTC Elastic	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$100.00 ➝ $130.00	Overweight ➝ Overweight
ESTC Elastic	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$100.00 ➝ $135.00	Overweight ➝ Overweight
ESTC Elastic	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$110.00 ➝ $130.00	Outperform ➝ Outperform
ESTC Elastic	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$100.00 ➝ $130.00	Overweight ➝ Overweight
ESTC Elastic	Upgraded by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$95.00 ➝ $135.00	Neutral ➝ Outperform
ESTC Elastic	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$94.00 ➝ $120.00	Neutral ➝ Neutral
ESTC Elastic	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%		Hold
ESTC Elastic	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.03 +14.8%	$125.00 ➝ $140.00	Outperform ➝ Outperform
EVH Evolent Health	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.25 -2.9%	$45.00 ➝ $15.00	Overweight ➝ Overweight
EWTX Edgewise Therapeutics	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.20 +0.7%	$45.00	Outperform
EXC Exelon	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.71 -1.5%	$46.00 ➝ $44.00	Equal Weight ➝ Equal Weight
EXE Chesapeake Energy	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$99.43 -1.5%	$102.00 ➝ $116.00	Outperform ➝ Outperform
EXPE Expedia Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$184.92 +0.8%	$150.00 ➝ $180.00	Equal Weight ➝ Equal Weight
FE FirstEnergy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.79 -1.0%	$52.00 ➝ $50.00	Overweight ➝ Overweight
FITB Fifth Third Bancorp	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.90 +1.7%	$43.00 ➝ $52.00	Neutral ➝ Neutral
FIX Comfort Systems USA	Initiated by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$491.06 +0.2%	$525.00	Buy
FL Foot Locker	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.13 +3.0%	$27.00	Buy
FLS Flowserve	Upgraded by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Dray Subscribe to MarketBeat All Access for the recommendation accuracy rating	$61.00 +1.6%	$57.00 ➝ $69.00	Sector Perform ➝ Outperform
FLUT Flutter Entertainment	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Andrews Subscribe to MarketBeat All Access for the recommendation accuracy rating	$275.52 +3.3%	$320.00	Buy
FRES Fresnillo	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 652.50 +0.8%		Overweight
FSLR First Solar	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$186.05 +2.3%	$245.00 ➝ $210.00	Overweight ➝ Overweight
FTNT Fortinet	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Dezort Subscribe to MarketBeat All Access for the recommendation accuracy rating	$92.77 -1.3%		Hold
GAP GAP	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.87 +12.8%	$23.00 ➝ $25.00	Market Perform ➝ Market Perform
GAP GAP	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.87 +12.8%	$26.00 ➝ $28.00	Neutral ➝ Neutral
GAP GAP	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.87 +12.8%	$32.00 ➝ $33.00	Outperform ➝ Outperform
GAP GAP	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.87 +12.8%	$35.00 ➝ $35.00	Buy ➝ Buy
GAP GAP	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.87 +12.8%	$14.00 ➝ $16.00	Sell ➝ Sell
GAP GAP	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.87 +12.8%	$28.00 ➝ $30.00	Overweight ➝ Overweight
GAP GAP	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.87 +12.8%	$25.00 ➝ $28.00	Neutral ➝ Neutral
GAP GAP	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.87 +12.8%	$29.00 ➝ $30.00	Overweight ➝ Overweight
Watch this before it gets removed (Ad) If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now.
GAP GAP	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.87 +12.8%	$31.00 ➝ $32.00	Overweight ➝ Overweight
GBTG Global Business Travel Group	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Ju Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.44 +4.0%	$11.00	Buy
GNRC Generac	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$189.08 +3.0%	$190.00 ➝ $200.00	Overweight ➝ Overweight
GNS Genus	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,718 +4.5%		Not Rated
GRAB Grab	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.07 -10.6%	$4.90 ➝ $4.90	Buy ➝ Underperform
GRI Grainger	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 235 +1.1%	GBX 336	Buy
HCA HCA Healthcare	Downgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ransom Subscribe to MarketBeat All Access for the recommendation accuracy rating	$324.93 -2.2%		Outperform ➝ Market Perform
HIPO Hippo	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.01 +6.1%	$25.00 ➝ $35.00	Market Outperform ➝ Market Outperform
HLS HLS Therapeutics	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$3.42 +3.3%	C$4.00 ➝ C$5.00
HOC Hochschild Mining	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 224 -0.9%		Overweight
HST Host Hotels & Resorts	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.25 +2.0%	$21.00 ➝ $20.50	Buy ➝ Buy
HUW Helios Underwriting	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 206 +5.1%	GBX 201 ➝ GBX 239	Buy
IBP Installed Building Products	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$217.09 +2.8%	$236.00 ➝ $241.00	Neutral ➝ Neutral
ICFI ICF International	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Sommer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$134.29 -0.9%	$180.00 ➝ $140.00	Hold ➝ Hold
INSM Insmed	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.15 -0.9%	$74.00 ➝ $83.00	Overweight ➝ Overweight
INTU Intuit	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$640.12 -5.7%	$790.00 ➝ $800.00	Buy ➝ Buy
INTU Intuit	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Jaluria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$640.12 -5.7%	$760.00 ➝ $760.00	Outperform ➝ Outperform
INTU Intuit	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$640.12 -5.7%	$712.00 ➝ $722.00	Outperform ➝ Outperform
INTU Intuit	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$640.12 -5.7%	$768.00 ➝ $765.00	Overweight ➝ Overweight
INTU Intuit	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$640.12 -5.7%	$685.00 ➝ $730.00	Equal Weight ➝ Equal Weight
INTU Intuit	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$640.12 -5.7%	$800.00 ➝ $775.00	Overweight ➝ Overweight
INTU Intuit	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$640.12 -5.7%	$795.00 ➝ $725.00	Buy ➝ Buy
INTU Intuit	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$640.12 -5.7%	$600.00 ➝ $640.00	Neutral ➝ Neutral
IQ iQIYI	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	F. Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.95 -3.5%		Hold
IQ iQIYI	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.95 -3.5%	$2.50 ➝ $1.80	Neutral ➝ Neutral
IVA Inventiva	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.62 -1.5%	$20.00 ➝ $17.00	Buy ➝ Buy
JACK Jack in the Box	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.50 -0.6%	$70.00 ➝ $57.00	Buy ➝ Buy
JANX Janux Therapeutics	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$50.31 +8.2%	$79.00	Outperform
JANX Janux Therapeutics	Upgraded by	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. La. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$50.31 +8.2%		Strong-Buy
JAZZ Jazz Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.67 +1.3%	$200.00 ➝ $200.00	Buy ➝ Buy
JD JD Sports Fashion	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 93.46 -2.1%	GBX 105	Neutral
JD JD Sports Fashion	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 93.46 -2.1%	GBX 110	Sell
JET2 Jet2	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,513 +0.9%	GBX 2,240 ➝ GBX 2,385	Buy
KC Kingsoft Cloud	Upgraded by	Nomura Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.21 +24.7%	$2.30 ➝ $6.70	Neutral ➝ Buy
KD Kyndryl	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.05 +1.7%	$40.00	Buy
KD Kyndryl	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.05 +1.7%	$33.00 ➝ $37.00	Outperform ➝ Outperform
KD Kyndryl	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.05 +1.7%	$33.00 ➝ $40.00	Positive ➝ Positive
KROS Keros Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Agrawal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$55.92 +3.9%		Overweight
KRRO Korro Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$52.31 +3.3%	$115.00 ➝ $115.00	Buy ➝ Buy
KURA Kura Oncology	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.80 +7.4%	$36.00 ➝ $29.00	Buy ➝ Buy
LBG LBG Media	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 133 +1.5%		Buy
LDOS Leidos	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$165.51 +0.5%	$205.00 ➝ $185.00	Buy ➝ Buy
LFCR Lifecore Biomedical	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Hewitt Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.31 +4.7%	$8.00 ➝ $10.00	Buy ➝ Buy
LII Lennox International	Initiated by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$657.69 +1.1%	$475.00	Sell
LIO Liontrust Asset Management	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 460 +2.0%	GBX 500	Hold
LMND Lemonade	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.28 -2.1%	$40.00 ➝ $60.00	Market Outperform ➝ Market Outperform
LTH Life Time Group	Initiated by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Wong Subscribe to MarketBeat All Access for the recommendation accuracy rating	$24.55 +0.7%	$29.00	Outperform
LULU Lululemon Athletica	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$317.11 +0.6%		Hold
LXRX Lexicon Pharmaceuticals	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.86 +11.6%		Hold
MAG MAG Silver	Target Raised by	Panmure Gordon Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$21.68 -0.8%	C$26.40 ➝ C$27.10
Financial Prophecy (Ad) The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier. Including the name of the #1 company to buy.
MASI Masimo	Reiterated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.96 +2.3%	$170.00 ➝ $190.00	Buy ➝ Buy
MFC Manulife Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$45.37 -0.6%	C$39.00 ➝ C$40.00
MGRC McGrath RentCorp	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$120.90 +1.2%	$124.00 ➝ $139.00	Outperform ➝ Outperform
MPWR Monolithic Power Systems	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Quatrochi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$580.81 +1.5%	$610.00	Equal Weight
MPWR Monolithic Power Systems	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$580.81 +1.5%	$950.00 ➝ $600.00	Buy ➝ Buy
MRU Metro	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$89.73 +0.8%	C$85.00 ➝ C$95.00
MXL MaxLinear	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Mobley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.54 -1.3%	$14.00	Equal Weight
NABL N-able	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.37 +0.9%	$16.50 ➝ $16.50	Buy ➝ Buy
NEE NextEra Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.00 -1.1%	$95.00 ➝ $94.00	Overweight ➝ Overweight
NKE NIKE	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$77.40 +3.1%	$84.00	Buy
NKSH National Bankshares	Upgraded by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Marinac Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.04 +4.3%	$38.00	Neutral ➝ Buy
NMRA Neumora Therapeutics	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.74 +0.5%	$29.00 ➝ $29.00	Outperform ➝ Outperform
NOVA Sunnova Energy International	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.90 +12.1%	$8.00 ➝ $4.50	Neutral ➝ Neutral
NTAP NetApp	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.34 -3.4%	$145.00 ➝ $160.00	Buy ➝ Buy
NTAP NetApp	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.34 -3.4%	$108.00 ➝ $120.00	Market Perform ➝ Market Perform
NTAP NetApp	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.34 -3.4%	$115.00 ➝ $121.00	Underperform ➝ Underperform
NTAP NetApp	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.34 -3.4%	$127.00 ➝ $132.00	Equal Weight ➝ Equal Weight
NTAP NetApp	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.34 -3.4%	$119.00 ➝ $132.00	Equal Weight ➝ Equal Weight
NTAP NetApp	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.34 -3.4%	$140.00 ➝ $145.00	Buy ➝ Buy
NTAP NetApp	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.34 -3.4%	$130.00 ➝ $135.00	Neutral ➝ Neutral
NTAP NetApp	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.34 -3.4%	$120.00	Neutral
NTAP NetApp	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.34 -3.4%	$135.00 ➝ $140.00	Equal Weight ➝ Equal Weight
NVDA NVIDIA	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$141.95 -3.2%	$90.00 ➝ $135.00	Neutral ➝ Neutral
NVDA NVIDIA	Reiterated by	Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$141.95 -3.2%	$155.00 ➝ $160.00	Buy ➝ Accumulate
NVGS Navigator	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.32 +2.5%	$20.00 ➝ $20.00	Buy ➝ Buy
NXPI NXP Semiconductors	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Quatrochi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$226.38 +0.8%	$250.00	Overweight
NXR Norcros	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 247	GBX 375	Buy
NXT Nextracker	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.85 +3.9%	$60.00 ➝ $47.00	Overweight ➝ Overweight
NXT Nextracker	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.85 +3.9%	$55.00 ➝ $55.00	Buy ➝ Buy
OCSL Oaktree Specialty Lending	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.85 +1.9%	$18.00 ➝ $18.00	Market Perform ➝ Market Perform
ON Onsemi	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Quatrochi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$69.62 +1.7%	$85.00	Overweight
ONON ON	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$58.13 +3.5%	$64.00	Buy
PANW Palo Alto Networks	Downgraded by	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Bersey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$383.36 -3.6%		Hold ➝ Moderate Sell
PANW Palo Alto Networks	Downgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$383.36 -3.6%	$304.00 ➝ $291.00	Hold ➝ Reduce
PCOR Procore Technologies	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.68 +1.9%	$73.00 ➝ $83.00	Buy ➝ Buy
PCOR Procore Technologies	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.68 +1.9%	$71.00 ➝ $85.00	Outperform ➝ Outperform
PCOR Procore Technologies	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.68 +1.9%	$70.00 ➝ $90.00	Overweight ➝ Overweight
PCOR Procore Technologies	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Kalia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.68 +1.9%	$66.00 ➝ $78.00	Equal Weight ➝ Equal Weight
PCOR Procore Technologies	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Luria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.68 +1.9%	$60.00 ➝ $70.00	Neutral ➝ Neutral
PCOR Procore Technologies	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.68 +1.9%	$68.00 ➝ $85.00	Overweight ➝ Overweight
PCOR Procore Technologies	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.68 +1.9%	$75.00 ➝ $85.00	Overweight ➝ Overweight
PCOR Procore Technologies	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.68 +1.9%	$70.00 ➝ $84.00	Buy ➝ Buy
PCOR Procore Technologies	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.68 +1.9%	$67.00 ➝ $83.00	Buy ➝ Buy
PCOR Procore Technologies	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Sherman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.68 +1.9%	$70.00 ➝ $82.00	Buy ➝ Buy
PCOR Procore Technologies	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.68 +1.9%	$70.00 ➝ $85.00	Sector Outperform ➝ Sector Outperform
PDD PDD	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$100.07 -3.9%	$170.00 ➝ $105.00	Overweight ➝ Neutral
PDD PDD	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$100.07 -3.9%	$185.00 ➝ $160.00	Buy ➝ Buy
PEB Pebblebrook Hotel Trust	Upgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.51 +3.9%	$14.75 ➝ $15.00	Hold ➝ Buy
PG Procter & Gamble	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$176.28 +2.0%	$188.00 ➝ $190.00	Overweight ➝ Overweight
PMTS CPI Card Group	Initiated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Heckmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	$29.75 +4.1%	$36.00	Buy
PNG Kraken Robotics	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$2.09 -2.3%	C$2.00 ➝ C$2.50
PNW Pinnacle West Capital	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$92.93 -0.7%	$82.00 ➝ $81.00	Equal Weight ➝ Equal Weight
POET POET Technologies	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.01 -0.7%	$3.50 ➝ $5.50	Buy ➝ Buy
PRTH Priority Technology	Target Raised by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.02 -4.0%	$8.00 ➝ $13.00	Buy ➝ Buy
PRTH Priority Technology	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Switzer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.02 -4.0%	$9.00 ➝ $10.00	Market Perform ➝ Market Perform
PSN Parsons	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$99.05 -0.3%	$130.00 ➝ $110.00	Buy ➝ Buy
PYCR Paycor HCM	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.48 +2.0%	$20.00 ➝ $20.00	Buy ➝ Buy
PYPL PayPal	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.77 +2.3%	$88.00	Neutral
PZC PZ Cussons	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 80.80 +2.9%	GBX 120	Buy
QED Quadrise	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1.95 +26.6%		House Stock
RBC RBC Bearings	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Barger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$336.82 +3.8%	$375.00	Sector Weight ➝ Overweight
RBLX Roblox	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.38 +0.1%	$60.00 ➝ $60.00	Strong-Buy ➝ Strong-Buy
RBRK Rubrik	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Heath Subscribe to MarketBeat All Access for the recommendation accuracy rating	$51.05 +3.9%	$48.00 ➝ $57.00	Overweight ➝ Overweight
REAL Real Matters	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$6.38 +0.2%	C$10.50 ➝ C$9.00
REAL Real Matters	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$6.38 +0.2%	C$10.00 ➝ C$8.50
REAL Real Matters	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$6.38 +0.2%	C$7.50 ➝ C$7.00
REPL Replimune Group	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.93 +35.1%	$14.00 ➝ $18.00	Outperform ➝ Outperform
REPL Replimune Group	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.93 +35.1%	$17.00 ➝ $17.00	Buy ➝ Buy
RGA Reinsurance Group of America	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$230.70 +0.7%	$250.00 ➝ $255.00	Overweight ➝ Overweight
RLYB Rallybio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.02 +3.0%	$5.00 ➝ $5.00	Buy ➝ Buy
ROKU Roku	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Hodulik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$69.20 +0.8%	$73.00	Neutral
ROOT Root	Downgraded by	Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Carletti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$109.23 -0.2%		Strong-Buy ➝ Hold
ROOT Root	Downgraded by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$109.23 -0.2%		Outperform ➝ Market Perform
ROST Ross Stores	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$146.09 +2.2%	$180.00 ➝ $180.00	Buy ➝ Buy
ROST Ross Stores	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$146.09 +2.2%	$171.00 ➝ $173.00	Overweight ➝ Overweight
ROST Ross Stores	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$146.09 +2.2%	$170.00 ➝ $180.00	Outperform ➝ Outperform
RUN Sunrun	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.51 +2.8%	$23.00 ➝ $11.00	Overweight ➝ Neutral
RUS Russel Metals	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$44.24 +1.5%	C$54.50 ➝ C$57.00
SBRY J Sainsbury	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 253.80 +2.8%		House Stock
SGE The Sage Group	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,286 +1.6%	GBX 970 ➝ GBX 1,090	Sell
SGE The Sage Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,286 +1.6%	£135 ➝ £145	Buy
SGE The Sage Group	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,286 +1.6%	GBX 1,170 ➝ GBX 1,350	Hold
SHLS Shoals Technologies Group	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.83 +9.8%	$10.00 ➝ $8.00	Overweight ➝ Overweight
SHOO Steven Madden	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$43.40 +1.4%		Hold
SKX Skechers U.S.A.	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$61.69 +1.1%		Hold
SLG SL Green Realty	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$79.63 +0.6%	$70.00 ➝ $72.00	Hold ➝ Hold
SLQT SelectQuote	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.86 +9.6%	$4.00 ➝ $4.00	Sector Perform ➝ Sector Perform
SNPS Synopsys	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Mobley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$565.07 +1.3%	$570.00	Equal Weight
SO Southern	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.60 -0.6%	$88.00 ➝ $85.00	Equal Weight ➝ Equal Weight
SPT Spirent Communications	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 171 +0.4%	GBX 225	Buy
SR Spire	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.55 +2.7%	$70.00 ➝ $69.00	Hold ➝ Hold
SR Spire	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.55 +2.7%	$77.00 ➝ $75.00	Equal Weight ➝ Equal Weight
STEM Stem	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.39 +8.3%	$1.50 ➝ $0.30	Neutral ➝ Neutral
TFSL TFS Financial	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Butler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.52 +1.0%	$15.00	Neutral
THC Tenet Healthcare	Downgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ransom Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.63 -2.9%	$195.00 ➝ $195.00	Strong-Buy ➝ Outperform
TJX TJX Companies	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$121.47 +1.4%	$130.00 ➝ $132.00	Buy ➝ Buy
TKR Timken	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Barger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$75.96 +1.0%		Overweight ➝ Sector Weight
TMDX TransMedics Group	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.04 -4.2%	$109.00 ➝ $109.00	Buy ➝ Hold
TT Trane Technologies	Initiated by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$417.49 +0.5%	$500.00	Buy
TTD Trade Desk	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.70 +1.8%	$133.00 ➝ $150.00	Outperform ➝ Outperform
TTWO Take-Two Interactive Software	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$188.15 +0.8%	$176.00 ➝ $211.00	Buy ➝ Buy
TXN Texas Instruments	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Quatrochi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$198.00 -0.1%	$215.00	Equal Weight
UAA Under Armour	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.52 +3.0%		Hold
UGI UGI	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.50 +15.0%	$28.00	Buy
UMBF UMB Financial	Initiated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Arfstrom Subscribe to MarketBeat All Access for the recommendation accuracy rating	$125.00 +1.5%	$130.00	Sector Perform
UNCY Unicycive Therapeutics	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Jackson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.53	$3.00 ➝ $3.00	Speculative Buy ➝ Speculative Buy
USAC USA Compression Partners	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.72 -0.5%	$27.00 ➝ $27.00	Sector Perform ➝ Sector Perform
VHI Vitalhub	Target Set by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$10.84 +5.8%	C$13.00	Buy
VKTX Viking Therapeutics	Initiated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$52.59 +1.9%	$109.00	Buy
VNRX VolitionRx	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.79 -2.5%		Hold
VST Vistra	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$161.92 -2.8%	$135.00 ➝ $169.00	Overweight ➝ Overweight
VSTS Vestis	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.02 +2.6%	$15.00 ➝ $16.00	Neutral ➝ Neutral
VSTS Vestis	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.02 +2.6%	$13.60 ➝ $15.00	Neutral ➝ Neutral
VSTS Vestis	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.02 +2.6%	$10.00 ➝ $13.00	Underweight ➝ Underweight
WALD Waldencast	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.32 -3.5%	$5.00 ➝ $6.00	Buy ➝ Buy
WAY Waystar	Upgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.25 +0.4%	$40.00 ➝ $40.00	Outperform ➝ Strong-Buy
WMG Warner Music Group	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.85 +2.1%	$32.00 ➝ $31.00	Equal Weight ➝ Equal Weight
WMG Warner Music Group	Reiterated by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nollen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.85 +2.1%	$30.00 ➝ $30.00	Neutral ➝ Neutral
WMG Warner Music Group	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.85 +2.1%	$41.00 ➝ $40.00	Overweight ➝ Overweight
WMG Warner Music Group	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.85 +2.1%	$44.00 ➝ $44.00	Buy ➝ Buy
WMT Walmart	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$90.44 +2.3%	$78.00 ➝ $90.00	Overweight ➝ Overweight
WSO Watsco	Initiated by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$554.79 +1.6%		Neutral
XEL Xcel Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.35 0.0%	$74.00 ➝ $72.00	Equal Weight ➝ Equal Weight
XPEV XPeng	Upgraded by	China Renaissance Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.91 -3.1%	$16.70	Hold ➝ Buy
XPS XPS Pensions Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 358 +0.3%	GBX 435	Buy
ZGN Ermenegildo Zegna	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.70 +0.4%	$7.20	Underweight
ZM Zoom Video Communications	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$85.88 +5.8%	$78.00 ➝ $78.00	Buy ➝ Buy
ZS Zscaler	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$210.96 +1.8%	$220.00 ➝ $245.00	Overweight ➝ Overweight
ZYME Zymeworks	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.29 +4.5%	$12.00 ➝ $12.00	Neutral ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:54 AM ET.

(Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

analyst ratings Headlines

Vertiv’s Cool Tech Makes Its Stock Red-Hot
By Jeffrey Neal Johnson | November 23, 2024
View Vertiv’s Cool Tech Makes Its Stock Red-Hot
MarketBeat Week in Review – 11/18 - 11/22
By Chris Markoch | November 23, 2024
View MarketBeat Week in Review – 11/18 - 11/22
2 Finance Stocks With Competitive Advantages You Can't Ignore
By Leo Miller | November 23, 2024
View 2 Finance Stocks With Competitive Advantages You Can't Ignore
Trump raced to pick many Cabinet posts. He took more time to settle on a treasury secretary
By The Associated Press | November 23, 2024
View Trump raced to pick many Cabinet posts. He took more time to settle on a treasury secretary
3 Hot Stock Trends to Ride Into 2025
By Thomas Hughes | November 19, 2024
View 3 Hot Stock Trends to Ride Into 2025
ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
By Leo Miller | November 16, 2024
View ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Amazon: Why Analysts Think It's a Solid Buy Ahead of Earnings
By Sam Quirke | October 28, 2024
View Amazon: Why Analysts Think It's a Solid Buy Ahead of Earnings

Top Headlines and Offers

View All

Tesla Investors Continue to Profit From the Trump Trade
By Chris Markoch | November 22, 2024
View Tesla Investors Continue to Profit From the Trump Trade
Indigenous leaders travel to UK from Peru to draw attention to oil damage and banking
By The Associated Press | November 22, 2024
View Indigenous leaders travel to UK from Peru to draw attention to oil damage and banking
Watch this before it gets removed
From Porter & Company(Ad)
View Watch this before it gets removed
5 Dividend ETFs to Buy and Hold Forever
By Ryan Hasson | November 20, 2024
View 5 Dividend ETFs to Buy and Hold Forever
Stock market today: Wall Street gains ground as it notches a winning week and another Dow record
By The Associated Press | November 21, 2024
View Stock market today: Wall Street gains ground as it notches a winning week and another Dow record
Don't Miss a Second Chance to Buy These 2024 Winners for 2025
By Thomas Hughes | November 20, 2024
View Don't Miss a Second Chance to Buy These 2024 Winners for 2025
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits(Ad)
View [625,000% Gain] – Are You Ready for the Next Altcoin Boom?
Traders Are Flocking Back to Oil: What’s Fueling the Optimism
By Gabriel Osorio-Mazilli | November 19, 2024
View Traders Are Flocking Back to Oil: What’s Fueling the Optimism
Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
By Leo Miller | November 18, 2024
View Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
Why SoundHound AI Could Be the Next AI Powerhouse
By Jeffrey Neal Johnson | November 21, 2024
View Why SoundHound AI Could Be the Next AI Powerhouse
4 Reasons to Grab Shares of Grab Holdings Before 2024 Ends
By Jea Yu | November 19, 2024
View 4 Reasons to Grab Shares of Grab Holdings Before 2024 Ends
3 Ultra-High Dividend Yield Stocks for the New Year
By Nathan Reiff | November 18, 2024
View 3 Ultra-High Dividend Yield Stocks for the New Year

Stock Forecasts and Research Tools

Today's Ratings

Top Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings